You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Details for Patent: 10,981,919


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,981,919 protect, and when does it expire?

Patent 10,981,919 protects UKONIQ and is included in one NDA.

This patent has fifty-five patent family members in thirty-one countries.

Summary for Patent: 10,981,919
Title:Selective PI3K delta inhibitors
Abstract: The present invention relates to selective inhibitors of PI3K delta protein kinases, methods of preparing them, pharmaceutical compositions containing them and methods of treatment and/or prevention of kinase mediated diseases or disorders with them.
Inventor(s): Vakkalanka; Swaroop K. (La Chaux-de-Fonds, CH), Muthuppalaniappan; Meyyappan (Hyderabad, IN), Nagarathnam; Dhanapalan (Bethany, CT)
Assignee: Rhizen Pharmaceuticals SA (Basel, CH)
Application Number:16/776,327
Patent Claim Types:
see list of patent claims
Use; Composition; Compound;

Drugs Protected by US Patent 10,981,919

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Tg Theraps UKONIQ umbralisib tosylate TABLET;ORAL 213176-001 Feb 5, 2021 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial RELAPSED OR REFRACTORY MARGINAL ZONE LYMPHOMA (MZL) WHO HAVE RECEIVED AT LEAST ONE PRIOR ANTI-CD20-BASED REGIMEN ⤷  Try a Trial
Tg Theraps UKONIQ umbralisib tosylate TABLET;ORAL 213176-001 Feb 5, 2021 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA (FL) WHO HAVE RECEIVED AT LEAST THREE PRIOR LINES OF SYSTEMIC THERAPY ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 10,981,919

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
India2692/CHE/2012Jul 4, 2012

International Family Members for US Patent 10,981,919

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 091677 ⤷  Try a Trial
Australia 2013285081 ⤷  Try a Trial
Brazil 112014033055 ⤷  Try a Trial
Canada 2876995 ⤷  Try a Trial
Chile 2014003511 ⤷  Try a Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.